These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Medical prescriptions in haemodialysis patients: critical analysis]. Riemer E; Werling E; Kribs M; Hamman De Compte A; Dimitrov Y Nephrol Ther; 2005 Oct; 1(4):234-40. PubMed ID: 16895690 [TBL] [Abstract][Full Text] [Related]
25. [Drug therapy in the elderly: too much or too little, what to do? A new assessment system: fit for the aged (FORTA]. Wehling M Dtsch Med Wochenschr; 2008 Oct; 133(44):2289-91. PubMed ID: 18946857 [No Abstract] [Full Text] [Related]
26. Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics. Nebert DW; Vesell ES Trends Pharmacol Sci; 2006 Nov; 27(11):580-6. PubMed ID: 17005258 [TBL] [Abstract][Full Text] [Related]
27. Practical therapeutics--drug therapy. Juma FD East Afr Med J; 1982 Apr; 59(4):238-40. PubMed ID: 7140608 [No Abstract] [Full Text] [Related]
28. [Contemporary drug therapy: dramatic dangers and the optimism of ability]. Mukhin NA; Moiseev SV; Fomin VV Klin Med (Mosk); 2005; 83(8):13-9. PubMed ID: 16218358 [No Abstract] [Full Text] [Related]
29. [Are children in the shadow region of drug therapy]. Hämäläinen M Duodecim; 2001; 117(18):1781-2. PubMed ID: 12181973 [No Abstract] [Full Text] [Related]
30. Evolution of drug-drug interactions: a personal viewpoint. Hartshorn EA Ann Pharmacother; 2006 Jan; 40(1):112-3. PubMed ID: 16368920 [No Abstract] [Full Text] [Related]
31. Natural product and drugs interactions, its clinical implication in drug therapy management. Joshi R; Medhi B Saudi Med J; 2008 Mar; 29(3):333-9. PubMed ID: 18327355 [TBL] [Abstract][Full Text] [Related]
32. Value of post-registration studies for reimbursement renewal. Molimard M; Bamberger M; Vray M Therapie; 2009; 64(3):203-13. PubMed ID: 19671433 [TBL] [Abstract][Full Text] [Related]
33. [Drug development--from receptor research to therapy]. Lammintausta R; Scheinin M Duodecim; 1998; 114(10):957-66. PubMed ID: 11524784 [No Abstract] [Full Text] [Related]
34. [Drug therapy in the aged: too much and too little, what to do? A new evaluation system: fit for the aged (FORTA)]. Werner H Dtsch Med Wochenschr; 2009 Jan; 134(3):95-6; author reply 96. PubMed ID: 19142841 [No Abstract] [Full Text] [Related]
35. [Examination of drug therapy quality in obligatory medical insurance system]. Baturin VA; Bulgakova TIa; Isaeva TI; Kolodiĭchuk EV; Shchetinin EV Med Tr Prom Ekol; 1999; (12):37-9. PubMed ID: 11965739 [No Abstract] [Full Text] [Related]
36. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency. Schultheis LW; Rappaport BA Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189 [No Abstract] [Full Text] [Related]
37. [Drug interactions in the practice. Which combinations are taboo?]. Zolk O; el-Armouche A; Eschenhagen T MMW Fortschr Med; 2001 Dec; 143(51-52):24-32. PubMed ID: 11824161 [No Abstract] [Full Text] [Related]
38. Pharmacy's framework for drug therapy management. Penna P Manag Care Interface; 2002 Jul; 15(7):33-4. PubMed ID: 12143294 [No Abstract] [Full Text] [Related]
39. [The search for risk factors and the therapeutic consequences. Drug interactions]. Diquet B; Lainé-Cessac P Rev Prat; 2005 Mar; 55(5):541-5. PubMed ID: 15895960 [No Abstract] [Full Text] [Related]
40. Pharmacology and therapeutics in dentistry. Seymour RA Periodontol 2000; 2008; 46():7-8. PubMed ID: 18201342 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]